Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 288.64% · OPTIONAL
· Surgical & Medical Instruments & Apparatus
RESEARCH SNAPSHOTOrchestra BioMed Holdings, Inc.'s latest supported as-filed period reports revenue of $88,000. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 288.64% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -21968.18% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -89.47% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 284.09% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 71.59% · CORE
Level · gp.fundamentals.operating_margin
Raw value -25404.55% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Capital expenditure increased 647.1%; Capex / revenue moved 28457 bp higher.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Inventory increased 35.1%; Inventory / revenue moved 26196 bp higher.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Shares outstanding increased 11.4%; SBC / revenue moved 245783 bp higher.
2 evidence-backed componentsCapital expenditure changed +647.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
OBIO · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001104659-26-107143SEC ↗8-KSep 8, 2026Period Sep 8, 20260001104659-26-105733SEC ↗4Sep 8, 2026Period Sep 3, 20260001104659-26-105690SEC ↗4Sep 2, 2026Period Sep 1, 20260001104659-26-104739SEC ↗4Aug 28, 2026Period Aug 26, 20260001104659-26-103210SEC ↗4Aug 28, 2026Period Aug 26, 20260001104659-26-103209SEC ↗4Aug 28, 2026Period Aug 26, 20260001104659-26-103205SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Sep 10, 2026Filed Sep 11, 2026 | Hochman David PSee Remarks | Tax WithholdingDirect | 3,283 | $6 | $19,074 | Form 4 ↗ |
| Sep 10, 2026Filed Sep 11, 2026 | Hochman David PSee Remarks | Tax WithholdingIndirect | 3,283 | $6 | $19,074 | Form 4 ↗ |
| Sep 3, 2026Filed Sep 8, 2026 | Hochman David PSee Remarks | Open Market PurchaseDirect | 10,000 | $5 | $47,900 | Form 4 ↗ |
| Sep 1, 2026Filed Sep 2, 2026 | Sherman DarrenSee Remarks | Open Market SaleDirect | 15,000 | $5 | $74,100 | Form 4 ↗ |
| Aug 12, 2026 |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 18852.27% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 2846.59% · OPTIONAL
Current assets changed +210.0% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Total assets changed +170.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Working capital changed +419.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Trade receivables changed -38.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Free-cash-flow proxy changed -25.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating cash flow changed -24.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001104659-26-097195| Pacitti DavidDirector |
| Tax WithholdingDirect |
| 3,761 |
| $4 |
| $16,624 |
| Form 4 ↗ |